We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
TLPH

Price
1.24
Stock movement up
+0.01 (0.81%)
Company name
Talphera Inc.
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
56.49M
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
24.00%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-30

DIVIDENDS

TLPH does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-0.47

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash6.79M
Net receivables0.00
Total current assets7.70M
Goodwill0.00
Intangible assets8.82M
Property, plant and equipment0.00
Total assets16.52M
Accounts payable835.00K
Short/Current long term debt6.50M
Total current liabilities2.63M
Total liabilities9.89M
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.25
Daily high1.27
Daily low1.21
Daily Volume104K
All-time high262.40
1y analyst estimate3.25
Beta0.25
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
TLPHS&P500
Current price drop from All-time high-99.53%-1.10%
Highest price drop-99.85%-19.00%
Date of highest drop7 Aug 20258 Apr 2025
Avg drop from high-99.75%-2.76%
Avg time to new high-5 days
Max time to new high266 days89 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
TLPH (Talphera Inc.) company logo
Marketcap
56.49M
Marketcap category
Small-cap
Description
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.
Employees
13
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...